- Home
- TGHL vs XAIR Comparison
TGHL vs XAIR Comparison
Compare TGHL & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGHL
- XAIR
- Stock Information
- Founded
- TGHL 2020
- XAIR 2011
- Country
- TGHL Singapore
- XAIR United States
- Employees
- TGHL N/A
- XAIR N/A
- Industry
- TGHL EDP Services
- XAIR Medical/Dental Instruments
- Sector
- TGHL Technology
- XAIR Health Care
- Exchange
- TGHL Nasdaq
- XAIR Nasdaq
- Market Cap
- TGHL 15.9M
- XAIR 17.0M
- IPO Year
- TGHL 2025
- XAIR N/A
- Fundamental
- Price
- TGHL $0.58
- XAIR $1.32
- Analyst Decision
- TGHL
- XAIR Strong Buy
- Analyst Count
- TGHL 0
- XAIR 1
- Target Price
- TGHL N/A
- XAIR $11.00
- AVG Volume (30 Days)
- TGHL 110.4K
- XAIR 1.2M
- Earning Date
- TGHL 05-01-2026
- XAIR 11-10-2025
- Dividend Yield
- TGHL N/A
- XAIR N/A
- EPS Growth
- TGHL N/A
- XAIR N/A
- EPS
- TGHL N/A
- XAIR N/A
- Revenue
- TGHL $173,668.00
- XAIR $5,802,000.00
- Revenue This Year
- TGHL N/A
- XAIR $261.11
- Revenue Next Year
- TGHL N/A
- XAIR $151.82
- P/E Ratio
- TGHL N/A
- XAIR N/A
- Revenue Growth
- TGHL 84.40
- XAIR 147.74
- 52 Week Low
- TGHL $0.53
- XAIR $1.32
- 52 Week High
- TGHL $4.25
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- TGHL N/A
- XAIR 23.26
- Support Level
- TGHL N/A
- XAIR $1.36
- Resistance Level
- TGHL N/A
- XAIR $1.53
- Average True Range (ATR)
- TGHL 0.00
- XAIR 0.14
- MACD
- TGHL 0.00
- XAIR -0.05
- Stochastic Oscillator
- TGHL 0.00
- XAIR 4.82
About TGHL The GrowHub Limited Class A Ordinary Shares
The Growhub Ltd operates at the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, It has developed a multi-faceted approach to address industry challenges. its business currently comprises two main divisions, which are the GrowHub Platform and its product trading facilitation offering.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.